NCT03748524View on ClinicalTrials.gov

Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

September 30, 2021

Study Completion Date

June 20, 2022

Conditions
Immunity, Cellular
Interventions
DRUG

Influenza Vaccine

Influenza Vaccine,Quadrivalent SIngle vaccination all participants at day 0

Trial Locations (1)

63110

Washington University School of Medicine Infectious Disease Clinical Research Unit, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03748524 - Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus Vaccine | Biotech Hunter | Biotech Hunter